Hosken Consolidated Investments Limited (JSE:HCI)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 16,125
-151 (-0.93%)
Aug 20, 2026, 10:43 AM SAST
JSE:HCI Income Statement
Financials in millions ZAR. Fiscal year is April - March.
Millions ZAR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 24,172 | 23,437 | 23,733 | 22,899 | 19,060 | |
Revenue Growth | 3.14% | -1.25% | 3.64% | 20.14% | 35.31% |
Cost of Revenue | 18,744 | 18,195 | 17,686 | 17,260 | 14,049 |
Gross Profit | 5,429 | 5,242 | 6,047 | 5,639 | 5,011 |
Operating Expenses | 1,143 | 1,134 | 1,219 | 1,162 | 1,166 |
Operating Income | 4,286 | 4,108 | 4,828 | 4,477 | 3,844 |
Interest Expense | -1,188 | -1,397 | -1,425 | -1,195 | -1,322 |
Interest & Investment Income | 245.8 | 288.1 | 258.65 | 299.53 | 148.64 |
Earnings From Equity Investments | 523.69 | 77.44 | -171.75 | 198.35 | -93.61 |
Other Non Operating Income (Expenses) | -15 | -25.01 | -59.81 | -70.84 | 9.4 |
EBT Excluding Unusual Items | 3,852 | 3,051 | 3,430 | 3,709 | 2,586 |
Impairment of Goodwill | - | - | - | - | -4.25 |
Gain (Loss) on Sale of Investments | 755.63 | 6,037 | 477.05 | 152.38 | 181.41 |
Asset Writedown | -70.11 | -1,529 | -2,773 | 2,846 | 1,151 |
Other Unusual Items | 2.38 | - | - | - | - |
Pretax Income | 4,540 | 7,560 | 1,134 | 6,708 | 3,915 |
Income Tax Expense | 1,053 | 537.35 | 388.27 | 1,620 | 711.41 |
Earnings From Continuing Operations | 3,487 | 7,022 | 745.69 | 5,088 | 3,203 |
Earnings From Discontinued Operations | - | - | - | -9.06 | -1.15 |
Net Income to Company | 3,487 | 7,022 | 745.69 | 5,079 | 3,202 |
Minority Interest in Earnings | -948.64 | -298.11 | -93.79 | -1,872 | -1,124 |
Net Income | 2,538 | 6,724 | 651.9 | 3,207 | 2,079 |
Net Income to Common | 2,538 | 6,724 | 651.9 | 3,207 | 2,079 |
Net Income Growth | -62.25% | 931.46% | -79.67% | 54.29% | - |
Shares Outstanding (Basic) | 79 | 81 | 81 | 81 | 81 |
Shares Outstanding (Diluted) | 79 | 82 | 83 | 82 | 81 |
Shares Change | -3.45% | -0.37% | 0.35% | 1.68% | 0.09% |
EPS (Basic) | 32.13 | 83.14 | 8.06 | 39.66 | 25.70 |
EPS (Diluted) | 31.95 | 81.72 | 7.89 | 38.94 | 25.69 |
EPS Growth | -60.90% | 935.32% | -79.73% | 51.59% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 2,412 | 1,606 | 2,351 | 2,422 | 2,194 |
Free Cash Flow Per Share | 30.37 | 19.52 | 28.47 | 29.43 | 27.11 |
Dividend Per Share | 2.000 | 1.700 | 1.000 | 0.500 | - |
Dividend Growth | 17.65% | 70.00% | 100.00% | - | - |
Gross Margin | 22.46% | 22.36% | 25.48% | 24.63% | 26.29% |
Operating Margin | 17.73% | 17.53% | 20.34% | 19.55% | 20.17% |
Profit Margin | 10.50% | 28.69% | 2.75% | 14.01% | 10.90% |
Free Cash Flow Margin | 9.98% | 6.85% | 9.91% | 10.58% | 11.51% |
EBITDA | 5,348 | 5,163 | 5,938 | 5,639 | 5,011 |
EBITDA Margin | 22.13% | 22.03% | 25.02% | 24.63% | 26.29% |
D&A For EBITDA | 1,063 | 1,055 | 1,109 | 1,162 | 1,166 |
EBIT | 4,286 | 4,108 | 4,828 | 4,477 | 3,844 |
EBIT Margin | 17.73% | 17.53% | 20.34% | 19.55% | 20.17% |
Effective Tax Rate | 23.20% | 7.11% | 34.24% | 24.15% | 18.17% |
Revenue as Reported | 24,172 | 23,437 | 23,733 | 22,899 | 19,060 |